Sunshine Biopharma Warrant
SBFMW
4 hedge funds and large institutions have $2.94K invested in Sunshine Biopharma Warrant in 2026 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0.81% more ownership
Funds ownership: 2.12% → 2.93% (+0.81%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Securities
New York
|
+$1.04K |
| 2 |
Clear Street
New York
|
+$4 |
| 3 |
HRT Financial
New York
|
+$1 |
Top Sellers
SBFMW Hedge Fund Activity: Q3 2026 in Review
4 of the 8,173 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Warrant (SBFMW) for Q3 2026, worth a combined $2.94K — up 14% from $2.57K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SBFMW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $1.04K.
- 4 institutional investors held Sunshine Biopharma Warrant (SBFMW) as of Q3 2026, up from 3 in Q2 2026.
- Funds reported $2.94K of Sunshine Biopharma Warrant stock for Q3 2026, up 14% quarter-over-quarter.
- 1 fund opened new Sunshine Biopharma Warrant positions in Q3 2026 and 0 closed out, a net change of +1 holder.
- The largest Sunshine Biopharma Warrant buyer in Q3 2026 was Two Sigma Securities, an estimated $1.04K added.
Based on aggregated 13F filings for Q3 2026.